CellCept (mycophenolate mofetil)

CellCept is an immunosuppressant medication that, in combination with corticosteroids and either ciclosporin or tacrolimus, is indicated for the prevention of organ rejection in patients receiving kidney, heart or liver transplants. It is also indicated for the treatment of patients with Class III-V lupus nephritis.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement